ETF Managers Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
$507K Buy
6,131
+91
+2% +$7.53K 0.02% 450
2022
Q4
$451K Buy
6,040
+220
+4% +$16.4K 0.02% 383
2022
Q3
$481K Buy
5,820
+225
+4% +$18.6K 0.02% 438
2022
Q2
$537K Sell
5,595
-2,714
-33% -$260K 0.02% 428
2022
Q1
$973K Buy
8,309
+142
+2% +$16.6K 0.02% 284
2021
Q4
$1.07M Buy
8,167
+387
+5% +$50.6K 0.02% 277
2021
Q3
$883K Buy
7,780
+597
+8% +$67.8K 0.02% 293
2021
Q2
$744K Buy
7,183
+2,076
+41% +$215K 0.01% 308
2021
Q1
$423K Buy
5,107
+686
+16% +$56.8K 0.01% 520
2020
Q4
$396K Buy
4,421
+392
+10% +$35.1K 0.01% 448
2020
Q3
$316K Buy
4,029
+198
+5% +$15.5K 0.01% 452
2020
Q2
$260K Sell
3,831
-615
-14% -$41.7K 0.01% 494
2020
Q1
$291K Buy
4,446
+456
+11% +$29.8K 0.01% 318
2019
Q4
$309K Sell
3,990
-6,507
-62% -$504K 0.01% 357
2019
Q3
$760K Sell
10,497
-3,213
-23% -$233K 0.03% 220
2019
Q2
$847K Sell
13,710
-7,173
-34% -$443K 0.03% 203
2019
Q1
$1.33M Sell
20,883
-9,300
-31% -$593K 0.07% 140
2018
Q4
$1.54M Buy
30,183
+27,786
+1,159% +$1.42M 0.07% 145
2018
Q3
$139K Sell
2,397
-15,417
-87% -$894K 0.01% 312
2018
Q2
$2.35K Buy
17,814
+15,582
+698% +$2.06K 0.17% 77
2018
Q1
$101K Buy
2,232
+276
+14% +$12.5K 0.01% 278
2017
Q4
$73K Buy
1,956
+276
+16% +$10.3K 0.01% 352
2017
Q3
$61K Buy
1,680
+150
+10% +$5.45K 0.01% 242
2017
Q2
$112K Buy
+1,530
New +$112K 0.01% 169
2016
Q4
$18K Sell
600
-390
-39% -$11.7K 0.08% 56
2016
Q3
$39K Buy
+990
New +$39K 0.08% 50
2016
Q1
$54K Buy
+1,737
New +$54K 0.04% 120